The Modified Lateral Intercostal Artery Perforator Flap.


Journal

Plastic and reconstructive surgery. Global open
ISSN: 2169-7574
Titre abrégé: Plast Reconstr Surg Glob Open
Pays: United States
ID NLM: 101622231

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 08 2017
accepted: 10 10 2018
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 3 2019
Statut: epublish

Résumé

The main surgical options for treatment of breast cancer are breast-conserving surgery and mastectomy. BCS aims to achieve complete excision of the tumor while achieving a pleasing cosmetic result. Excision of tumors in the lateral aspect of the breast has been associated with issues such as contour deformities and asymmetry. Development of volume replacement techniques such as the lateral intercostal artery perforator flap (LICAP) aimed to address these issues. Our modification of the traditional LICAP offers a less visible scar, good access to the axilla, and no need to reposition the patient. All patients undergoing a modified LICAP were identified from our database. The lateral intercostal artery perforators were marked with ultrasound and 2 "lazy S" lines were drawn to mark the flap. The wide local excision (with or without axillary surgery) was performed and the flap mobilized to fill the defect. Twenty-two patients underwent modified LICAP in 14 months. The mean specimen weight was 86 g. Four patients (18%) had a re-excision for positive margins. Nineteen patients had axillary surgery performed at the time of their modified LICAP flap. No patients had a scar that extended posterior to the posterior axillary line; no patients required a separate incision for axillary surgery; and no patients needed to be repositioned intraoperatively. Our early experience with this innovative procedure has been favorable. The perioperative complication rate is low. Due to the relatively short follow-up, longer term outcomes such as postradiotherapy appearance are yet to be determined.

Sections du résumé

BACKGROUND BACKGROUND
The main surgical options for treatment of breast cancer are breast-conserving surgery and mastectomy. BCS aims to achieve complete excision of the tumor while achieving a pleasing cosmetic result. Excision of tumors in the lateral aspect of the breast has been associated with issues such as contour deformities and asymmetry. Development of volume replacement techniques such as the lateral intercostal artery perforator flap (LICAP) aimed to address these issues. Our modification of the traditional LICAP offers a less visible scar, good access to the axilla, and no need to reposition the patient.
METHODS METHODS
All patients undergoing a modified LICAP were identified from our database. The lateral intercostal artery perforators were marked with ultrasound and 2 "lazy S" lines were drawn to mark the flap. The wide local excision (with or without axillary surgery) was performed and the flap mobilized to fill the defect.
RESULTS RESULTS
Twenty-two patients underwent modified LICAP in 14 months. The mean specimen weight was 86 g. Four patients (18%) had a re-excision for positive margins. Nineteen patients had axillary surgery performed at the time of their modified LICAP flap. No patients had a scar that extended posterior to the posterior axillary line; no patients required a separate incision for axillary surgery; and no patients needed to be repositioned intraoperatively.
CONCLUSIONS CONCLUSIONS
Our early experience with this innovative procedure has been favorable. The perioperative complication rate is low. Due to the relatively short follow-up, longer term outcomes such as postradiotherapy appearance are yet to be determined.

Identifiants

pubmed: 30881825
doi: 10.1097/GOX.0000000000002066
pmc: PMC6416140
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2066

Références

N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
Ann Surg Oncol. 2005 Jul;12(7):539-45
pubmed: 15889210
J Plast Reconstr Aesthet Surg. 2006;59(6):644-52
pubmed: 16716957
Plast Reconstr Surg. 2009 Jul;124(1):28-38
pubmed: 19568041
Ann Surg Oncol. 2010 May;17(5):1375-91
pubmed: 20140531
J Surg Oncol. 2014 Jul;110(1):90-5
pubmed: 24889526

Auteurs

Farid Meybodi (F)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Annelise M Cocco (AM)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

David Messer (D)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Alexander Brown (A)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Kavitha Kanesalingam (K)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Elisabeth Elder (E)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Jeremy Hsu (J)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

James French (J)

estmead Breast Cancer Institute, Westmead Hospital; and University of Sydney.

Classifications MeSH